Isoniazid-Associated Hepatitis in 114 Patients

Gastroenterology - Tập 69 Số 2 - Trang 289-302 - 1975
Martin Black1,2,3,4,5,6,7,8,9, Jerry R. Mitchell1,2,3,4,5,6,7,8,9, Hyman J. Zimmerman1,2,3,4,5,6,7,8,9, Kamal G. Ishak1,2,3,4,5,6,7,8,9, Gary Epler1,2,3,4,5,6,7,8,9
1Armed Forces Institute of Pathology, Washint:-ton, D.C.; Center for Disease Control, Atlanta, Georgia
2Bureau of Adult Health Serv-ices, South Carolina Department of Health and Envi-ronmental Control,
3Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
4Laboratory of Chemical Pharmacology, Na-tional Heart and Lung Institute, Building 10, Room BN-115, Bethesda, Maryland 20014.
5Laboratory of Chemical Pharmacology, National Heart and Lung Institute, National in-stitutes. of Health, Bethesda, Maryland; Medical Service,
6Temple Univer-sity Health Sciences Center, Philadelphia, Pennsyl
7Temple University Health Sciences Center, Phila-delphia, Pennsylvania 19140.
8Tuberculosis Research Sec-tion, Center for Disease Control, Bethesda, Maryland
9Veterans Administration Hospi-tal, Washington, D.C.; Hepatic Branch,

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bernstein, 1952, The chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (Nydrazid) and related compounds, Am Rev Tuberc Pulm Dis, 65, 357

Steenken, 1952, Antituberculous properties of hydrazines of isonicotinic acid (Rimifon, Marsilid), Am Rev Tuber Pulm Dis, 65

Weinstein, 1970, Drugs used in the chemotherapy of leprosy and tuberculosis, chap 61, 1311

Comstock, 1972, Preventive treatment of untreated nonactive tuberculosis in an Eskimo population, Arch Environ Health, 25, 333, 10.1080/00039896.1972.10666182

Horwitz, 1966, Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland, Bull WHO, 35, 509

Ferebee, 1962, Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts, Am Rev Resp Dis, 85, 490

American Thoracic Society, 1967, Chemoprophylaxis for the prevention of tuberculosis; a statement by an ad hoc committee, Am Rev Resp Dis, 96, 558

Devadatta, 1960, Peripheral neuritis due to isoniazid, Bull WHO, 23, 587

Randolph, 1953, Toxic hepatitis with jaundice occurring in a patient treated with isoniazid, JAMA, 152, 38, 10.1001/jama.1953.63690010014007i

Gellis, 1955, Hepatitis following isoniazid, Dis Chest, 28, 462, 10.1378/chest.28.4.462

Haber, 1959, Icterus and febrile reactions in response to isonicotinic acid hydrazine, Ν Engl J Med, 260, 417, 10.1056/NEJM195902262600904

Merritt, 1959, Toxic hepatic necrosis (hepatitis) due to isoniazid: report of a case with cirrhosis and death due to hemorrhage from esophageal varrices, Ann Intern Med, 50, 804, 10.7326/0003-4819-50-3-804

Gillis, 1960, Unusual reactions to antituberculosis chemotherapy, Med J Aust, 2, 99, 10.5694/j.1326-5377.1960.tb87016.x

Cohen, 1961, Fatal hepatic necrosis secondary to isoniazid therapy, JAMA, 176, 877, 10.1001/jama.1961.63040230013013b

1961, Ν Engl J Med, 264, 1256, 10.1056/NEJM196106152642410

Davies, 1961, Jaundice due to isoniazid, Tubercle (Lond), 42, 504, 10.1016/S0041-3879(61)80140-2

Reynolds, 1962, Isoniazid jaundice and its relationship to iproniazid jaundice, Tubercle (Lond), 43, 375, 10.1016/S0041-3879(62)80006-3

Case records of the Massachusetts General Hospital, 1962, Ν Engl J Med, 267, 350, 10.1056/NEJM196208162670710

O'Sullivan, 1966, Isoniazid jaundice during the treatment of genitourinary tuberculosis, Tubercle (Lond), 47, 375

Cohen, 1967, Hepatitis por isoniazida, Prensa Med Argent, 54, 70

Lederman, 1968, Exchange transfusion as treatment of acute hepatic failure due to antituberculous drugs, Ann Intern Med, 68, 830, 10.7326/0003-4819-68-4-830

Assem, 1969, Liver damage and isoniazid allergy, Clin Exp Immunol, 5, 439

Martin, 1970, ArthaudJB: Hepatitis after isoniazid administration, Ν Engl J Med, 282, 433, 10.1056/NEJM197002192820808

Grossman, 1970, Jaundice and death from isoniazid, J Tenn Med Assoc, 63, 23

Rester, 1971, Isoniazid hepatotoxicity fact or fantasy, JAMA, 217, 699, 10.1001/jama.1971.03190050155026

Garibaldi, 1972, Isoniazid-associated hepatitis: report of an outbreak, Am Rev Resp Dis, 106, 357, 10.1164/arrd.1972.106.3.357

Moss, 1972, Isoniazid-associated hepatitis. A study of five cases, Am Rev Resp Dis, 106, 849, 10.1164/arrd.1972.106.6.849

Perera, 1969, Hepatocellular damage due to INH, 12

Maddrey, 1973, Boitnott JK: Isoniazid hepatitis, Ann Intern Med, 70, 1, 10.7326/0003-4819-79-1-1

Isoniazid and liver disease, 1971, Report of the ad hoc-committee on isoniazid and liver disease, Center for Disease Control, Am Rev Resp Dis, 104, 454, 10.1164/arrd.1971.104.3.454

Scharer, 1969, Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid, Ann Intern Med, 71, 1113, 10.7326/0003-4819-71-6-1113

Byrd, 1972, Isoniazid toxicity, JAMA, 220, 1471, 10.1001/jama.1972.03200110051009

Bailey, 1973, Disturbed hepatic function during isoniazid chemoprophylaxis, Am Rev Resp Dis, 107, 523, 10.1164/arrd.1973.107.4.523

Mitchell, 1975, Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy, Chest, 68, 181, 10.1378/chest.68.2.181

Zimmerman, 1972, Drug-Induced Hepatic Injury. Reprinted from Hypersensitivity to Drugs I.E.P.T

Rosen, 1970, Computer analysis of liver function tests and their interrelationships in 347 cases of viral hepatitis, Israel J Med Sci, 6, 67

Prince, 1970, Immunological distinction between infectious and serum hepatitis, Ν Engl J Med, 282, 987, 10.1056/NEJM197004302821801

1974, Morbidity and Mortality, 23, 97

1971, Annual Supplement, summary, vol. 20, 1

Harinasuta, 1971, Alcoholic steatonecrosis. 1. Relationship between severity of hepatic disease and presence of Mallory bodies in the liver, Gastroenterology, 60, 1036, 10.1016/S0016-5085(71)80031-8

Stead, 1973, Isoniazid hepatitis: backlash of progress, Ann Intern Med, 79, 125, 10.7326/0003-4819-79-1-125

Klatskin, 1968, Toxic and drug-induced hepatitis, 498

Adriany, 1960, Toxicity to para-amino salicylic acid and isoniazid, Dis Chest, 38, 107, 10.1378/chest.38.1.107

Alarcon-Segovia, 1971, Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment, Arthritis Rheum, 14, 748, 10.1002/art.1780140610

Mathews, 1971, Experience with lymphocyte transformation tests in the evaluation of allergy to aminosalicylic acid, isoniazid, and streptomycin (abstr), J Allergy, 47

Dove, 1972, Failure to demonstrate transformation of lymphocytes of patients with isoniazid associated hepatitis, Am Rev Resp Dis, 106, 485, 10.1164/arrd.1972.106.3.485

Mitchell, 1975, Metabolic activation of drugs to toxic substances, Gastroenterology, 68, 392, 10.1016/S0016-5085(75)80025-4

Rosenblum, 1960, Hepatocellular jaundice as a complication of iproniazid therapy, Arch Intern Med, 105, 583, 10.1001/archinte.1960.00270160081010

Kalow, 1962

A cooperative USPHS study. Isoniazid-related hepatitis: a USPHS surveillance study (in preparation)

Mitchell, 1975, Increased incidence of isoniazid hepatitis in rapid acetylators and possible relation to hydrazine metabolites, Clin Pharmacol Ther, 18, 70, 10.1002/cpt197518170

Rao, 1970, Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid, Br Med J, 3, 495, 10.1136/bmj.3.5721.495

Peters, 1965, Studies on the metabolic basis of the genetically determined capacities for isoniazid inactivation in man, J Pharmacol Exp Ther, 150, 298

Snodgrass, 1974, Possible mechanism of isoniazid-related hepatic injury (abstr), Clin Res, 22, 323A

Nelson, 1975, Metabolic activation of hydrazines to reactive intermediates: mechanistic implications for isoniazid and iproniazid hepatitis (abstr), Fed Proc, 34, 784